Search

Kauser M. Akhoon

Examiner (ID: 9527, Phone: (571)270-1026 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642, 1613
Total Applications
267
Issued Applications
151
Pending Applications
2
Abandoned Applications
116

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9338869 [patent_doc_number] => 20140065651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'DESTRUCTIBLE SURFACTANTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/075637 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9943 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075637 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/075637
Destructible surfactants and uses thereof Nov 7, 2013 Issued
Array ( [id] => 10373204 [patent_doc_number] => 20150258210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'MODIFIED ANTIBODY, ANTIBODY-CONJUGATE AND PROCESS FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/437808 [patent_app_country] => US [patent_app_date] => 2013-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 35639 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437808 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/437808
Modified antibody, antibody-conjugate and process for the preparation thereof Oct 22, 2013 Issued
Array ( [id] => 12960364 [patent_doc_number] => 09872924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-23 [patent_title] => Antibody-drug conjugate produced by binding through linker having hydrophilic structure [patent_app_type] => utility [patent_app_number] => 14/436458 [patent_app_country] => US [patent_app_date] => 2013-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 68073 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 422 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436458 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/436458
Antibody-drug conjugate produced by binding through linker having hydrophilic structure Oct 16, 2013 Issued
Array ( [id] => 10398251 [patent_doc_number] => 20150283259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'DRUG-PROTEIN CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/437571 [patent_app_country] => US [patent_app_date] => 2013-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9105 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437571 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/437571
DRUG-PROTEIN CONJUGATES Oct 10, 2013 Abandoned
Array ( [id] => 13207203 [patent_doc_number] => 10117952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Antibody-drug conjugate [patent_app_type] => utility [patent_app_number] => 14/435114 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 64369 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435114 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/435114
Antibody-drug conjugate Oct 9, 2013 Issued
Array ( [id] => 13207203 [patent_doc_number] => 10117952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Antibody-drug conjugate [patent_app_type] => utility [patent_app_number] => 14/435114 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 64369 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435114 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/435114
Antibody-drug conjugate Oct 9, 2013 Issued
Array ( [id] => 13207203 [patent_doc_number] => 10117952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Antibody-drug conjugate [patent_app_type] => utility [patent_app_number] => 14/435114 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 64369 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435114 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/435114
Antibody-drug conjugate Oct 9, 2013 Issued
Array ( [id] => 13207203 [patent_doc_number] => 10117952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Antibody-drug conjugate [patent_app_type] => utility [patent_app_number] => 14/435114 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 64369 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435114 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/435114
Antibody-drug conjugate Oct 9, 2013 Issued
Array ( [id] => 11814952 [patent_doc_number] => 09718894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-01 [patent_title] => 'Bioprocessing device' [patent_app_type] => utility [patent_app_number] => 14/046154 [patent_app_country] => US [patent_app_date] => 2013-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 12482 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046154 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/046154
Bioprocessing device Oct 3, 2013 Issued
Array ( [id] => 9661771 [patent_doc_number] => 08808741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Tamper resistant dosage forms' [patent_app_type] => utility [patent_app_number] => 14/040535 [patent_app_country] => US [patent_app_date] => 2013-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 43 [patent_no_of_words] => 66028 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14040535 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/040535
Tamper resistant dosage forms Sep 26, 2013 Issued
Array ( [id] => 9269752 [patent_doc_number] => 20140024669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'TAMPER RESISTANT DOSAGE FORMS' [patent_app_type] => utility [patent_app_number] => 14/038209 [patent_app_country] => US [patent_app_date] => 2013-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 66006 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14038209 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/038209
TAMPER RESISTANT DOSAGE FORMS Sep 25, 2013 Abandoned
Array ( [id] => 9269773 [patent_doc_number] => 20140024691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'FORMULATIONS OF BENDAMUSTINE' [patent_app_type] => utility [patent_app_number] => 14/031879 [patent_app_country] => US [patent_app_date] => 2013-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5785 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14031879 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/031879
Formulations of bendamustine Sep 18, 2013 Issued
Array ( [id] => 10331974 [patent_doc_number] => 20150216977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'STABLE PHARMACEUTICAL COMPOSITION, COMPRISING AN AQUEOUS SOLUTION OF AN ANTIBODY-DERIVED THERAPEUTICALLY ACTIVE PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/428860 [patent_app_country] => US [patent_app_date] => 2013-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8055 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428860 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/428860
STABLE PHARMACEUTICAL COMPOSITION, COMPRISING AN AQUEOUS SOLUTION OF AN ANTIBODY-DERIVED THERAPEUTICALLY ACTIVE PROTEIN Sep 17, 2013 Abandoned
Array ( [id] => 9250163 [patent_doc_number] => 08613941 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-12-24 [patent_title] => 'Synergistic antimicrobial composition' [patent_app_type] => utility [patent_app_number] => 14/025862 [patent_app_country] => US [patent_app_date] => 2013-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1948 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025862 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/025862
Synergistic antimicrobial composition Sep 12, 2013 Issued
Array ( [id] => 13156233 [patent_doc_number] => 10094834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-09 [patent_title] => Method of selecting individualized brain cancer therapy [patent_app_type] => utility [patent_app_number] => 14/424400 [patent_app_country] => US [patent_app_date] => 2013-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 5063 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 316 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424400 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/424400
Method of selecting individualized brain cancer therapy Aug 28, 2013 Issued
Array ( [id] => 9198851 [patent_doc_number] => 20130338166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'REDUCING SIDE EFFECTS OF TRAMADOL' [patent_app_type] => utility [patent_app_number] => 13/970198 [patent_app_country] => US [patent_app_date] => 2013-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9956 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970198 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/970198
REDUCING SIDE EFFECTS OF TRAMADOL Aug 18, 2013 Abandoned
Array ( [id] => 9223559 [patent_doc_number] => 20140018334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'Oral Dosage Forms of Bendamustine' [patent_app_type] => utility [patent_app_number] => 13/932785 [patent_app_country] => US [patent_app_date] => 2013-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10239 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13932785 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/932785
Oral Dosage Forms of Bendamustine Jun 30, 2013 Abandoned
Array ( [id] => 9206084 [patent_doc_number] => 20140005261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'RACECADOTRIL LIQUID COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/929975 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3716 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929975 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/929975
Racecadotril liquid compositions Jun 27, 2013 Issued
Array ( [id] => 13013917 [patent_doc_number] => 10030066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-24 [patent_title] => Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor [patent_app_type] => utility [patent_app_number] => 14/434743 [patent_app_country] => US [patent_app_date] => 2013-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5474 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434743 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/434743
Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor Jun 25, 2013 Issued
Array ( [id] => 9205014 [patent_doc_number] => 20140004190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'Solid Dosage Forms of Bendamustine' [patent_app_type] => utility [patent_app_number] => 13/917144 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20822 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917144 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/917144
Solid Dosage Forms of Bendamustine Jun 12, 2013 Abandoned
Menu